Table of Contents - Espicom

More documents

Recommendations

Info

Table of Contents iv © Espicom Business Intelligence © 2012 UBM Semiconductor Insights Diabetes Landscape: 1.5.2 Connectivity and Data Integration ............................................................................................................................32 The Role of Telemonitoring in Diabetes Care ....................................................................................................................................32 Safety Issues .............................................................................................................................................................................................33 1.5.3 Emerging Technologies ..............................................................................................................................................34 New-Generation Insulin Delivery Devices ......................................................................................................................................... 34 Development of a Closed-Loop System ..............................................................................................................................................35 Rival Technologies ..................................................................................................................................................................................35 1.6 MARKET EXPECTATIONS ........................................................................................................................................................ 38 Fig.1.13: Global Diabetes Device Market, 2011-2017E (US$ billion) ..............................................................................................................................................................38 Global Diabetes Market Forecast by Product Type, 2011-2017E (US$ million) ............................................................................................................................................. 39 Global Diabetes Market Forecast Growth Rates by Product, 2011-2017E (%) ............................................................................................................................................. 39 Fig.1.14: Global Monitoring Market Forecast, 2011-2017E (US$ billion) ....................................................................................................................................................... 39 Fig.1.15: Global Insulin Delivery Market Forecast, 2011-2017(E) (US$ billion) .............................................................................................................................................40 Fig.1.16: Diabetes Device Market by Product, 2017E ....................................................................................................................................................................................40 2.0 DIABETES MONITORING PRODUCTS .......................................................................................................41 Overview: Glucose Monitoring Products ...........................................................................................................................42 2.1 MARKET DYNAMICS ............................................................................................................................................................... 44 Fig.2.1: Global Glucose Monitoring Market, 2005-2011 (US$ billion)...........................................................................................................................................................44 Fig.2.2: Global Blood Monitoring Market Growth, 2005-2011 (%) .............................................................................................................................................................44 Fig.2.3: Glucose Monitoring Market by Product Type, 2011 ......................................................................................................................................................................... 45 Fig.2.4: Blood Glucose Testing Market by Geographic Region, 2011 ............................................................................................................................................................ 45 Public Companies’ Glucose Monitoring Sales, 2005-2011 (US$ million) ...................................................................................................................................................... 45 Fig.2.5: Glucose Monitoring Market Shares by Company, 2011 ...................................................................................................................................................................46 2.2 MANUAL SELF-MONITORING BLOOD GLUCOSE PRODUCTS .......................................................................................... 47 Fig.2.6: Example of a Classic BGM & Test Strip: Bayer’s Contour Meter .......................................................................................................................................................48 2.2.1 Current Market Environment .................................................................................................................................... 48 Fig.2.7: Global SMBG Market, 2005-2011 (US$ million) ...............................................................................................................................................................................49 Fig.2.8: Global SMBG Market Growth Rates, 2005-2011 (%) ......................................................................................................................................................................49 Fig.2.9: SMBG Market by Product Type, 2011 ...............................................................................................................................................................................................49 Regional Markets and Reimbursement ............................................................................................................................................. 50 Fig.2.10: SMBG Market by Region, 2011 .......................................................................................................................................................................................................50 Market Developments ............................................................................................................................................................................51 Fig.2.11: Mendor’s Discreet (left) & Roche’s Accu-Check Mobile with Attached Lancing Device (right) ....................................................................................................... 51 Fig.2.12: BodyTel Europe’s GlucoTel BGM ...................................................................................................................................................................................................... 51 Fig.2.13: Medisana’s GlucoDock Attached to an Apple iPhone ................................................................................................................................................................... 52 Accuracy Standards ................................................................................................................................................................................53 Market Forecast ...................................................................................................................................................................................... 54 Summary: SMBG Growth Drivers, Restraints & Opportunities .................................................................................................................................................................... 55 Fig.2.14: Global SMBG Market, 2011-2017E (US$ billion) ............................................................................................................................................................................. 55 Fig.2.15: Global SMBG Market Growth Rates, 2012-2017E (%) .................................................................................................................................................................... 56 2.2.2 Competitive Environment ..........................................................................................................................................56 Public Companies’ BGM Sales, 2005-2011 (US$ million) ............................................................................................................................................................................. 57 Fig.2.16: SMBG Market Share by Company, 2011 ......................................................................................................................................................................................... 57 Fig.2.17: United States SMBG Market Share by Company, 2011 ................................................................................................................................................................... 58 Fig.2.18: SMBG International Market Share by Company, 2011 ..................................................................................................................................................................58 2.2.3 Market-Leading Self-Testing Blood Glucose Meters ...............................................................................................59 1. Abbott’s Blood Glucose Monitors ....................................................................................................................................................59 2. Arkray’s Glucocard Products ............................................................................................................................................................ 60 3. Bayer’s Blood Glucose Monitoring Systems ...................................................................................................................................61 4. Contour USB ........................................................................................................................................................................................ 62 5. Contour, Contour TS, Contour Link and Breeze 2 ......................................................................................................................... 62 6. DIDGET Meter ..................................................................................................................................................................................... 63 7. Elite and Elite XL .................................................................................................................................................................................. 63 LifeScan OneTouch Products ................................................................................................................................................................ 63 May 2012
Diabetes Landscape: May 2012 © Espicom Business Intelligence © 2012 UBM Semiconductor Insights Table of Contents Nipro Diagnostics’ TRUE Products ...................................................................................................................................................... 66 Roche Diabetes Care’s Products ...........................................................................................................................................................67 2.2.4 Other Market Participants ..........................................................................................................................................68 Competing Self-Testing Blood Glucose Monitoring Products .......................................................................................................................................................................68 Product Highlights ..................................................................................................................................................................................71 2.2.5 Products in Development ...........................................................................................................................................77 Intuity Medical’s POGO Blood Glucose Monitoring System ........................................................................................................... 77 Pepex Biomedical’s Trio Products ....................................................................................................................................................... 77 2.3 CONTINUOUS GLUCOSE MONITORING .............................................................................................................................. 78 Fig.2.19: Example of a CGM: Medtronic’s Guardian REAL-Time System ....................................................................................................................................................... 78 2.3.1 The Benefits of CGM ....................................................................................................................................................78 2.3.2 Barriers to Adoption ...................................................................................................................................................79 The Cost of CGM ...................................................................................................................................................................................... 79 2.3.3 Clinical Trial Results - Highlighting Benefits and Drawbacks .................................................................................79 2.3.4 The TD1 Exchange: User Experiences of CGM ...........................................................................................................81 2.3.5 CGM Market Trends and Opportunities ....................................................................................................................82 Fig.2.20: Global CGM Market, 2006-2011 (US$ million) ..............................................................................................................................................................................82 Fig.2.21: Percentage of CGM Sales Volumes by Hardware & Consumables, 2011 ........................................................................................................................................ 82 Regional Adoption Rates, Regulatory and Reimbursement Environment ................................................................................. 83 Fig.2.22: CGM Market by Region, 2011 ......................................................................................................................................................................................................... 83 Future Prospects..................................................................................................................................................................................... 84 Fig.2.23: Global CGM Market Forecast, 2011-2017E (US$ million)................................................................................................................................................................ 85 Fig.2.24: Global CGM Market Forecast Growth Rates, 2011-2017E (%) .......................................................................................................................................................86 Summary: CGM Benefits, Challenges & Opportunities ................................................................................................................................................................................86 2.3.6 Competitive Environment ..........................................................................................................................................87 Leading Companies’ Reported CGM Sales, 2006-2011 (US$ million) ........................................................................................................................................................... 87 Fig.2.25: Global CGM Market Shares by Company, 2011 ..............................................................................................................................................................................88 Fig.2.26: US CGM Market Shares by Company, 2011 ....................................................................................................................................................................................88 Fig.2.27: International CGM Market Shares by Company, 2011 ...................................................................................................................................................................89 2.3.7 Currently-Available Products .....................................................................................................................................89 Medtronic’s Guardian REAL-Time CGM System ............................................................................................................................... 89 DexCom’s CGMs ...................................................................................................................................................................................... 90 Abbott’s FreeStyle Navigator ...............................................................................................................................................................91 A Menarini Diagnostics’ GlucoDay S ....................................................................................................................................................92 2.3.8 Products in Development ...........................................................................................................................................92 Abbott’s Navigator II ...............................................................................................................................................................................92 DexCom’s Research and Development ...............................................................................................................................................92 New-Generation Implantable CGM Sensors ......................................................................................................................................93 Minimally-Invasive CGM in Development ......................................................................................................................................... 95 2.4 NON-INVASIVE GLUCOSE MONITORING ........................................................................................................................... 100 2.4.1 Competitive Environment ....................................................................................................................................... 100 2.4.2 AIMEDICS’ HypoMon ................................................................................................................................................101 2.4.3 Biosign Technologies’ UFIT TEN-20 Non-Invasive Blood Pressure and Glucose Meter 101 2.3.4 Biovotion’s Multisensor Glucose Monitoring System ............................................................................................102 2.3.5 Integrity Applications’ GlucoTrack ..........................................................................................................................103 Clinical Study Results ........................................................................................................................................................................... 103 2.3.6 Optical Technologies.................................................................................................................................................105 C8 MediSensors Optical Glucose Monitor ....................................................................................................................................... 105 EyeSense’s Optical Sensor .................................................................................................................................................................. 105 Freedom Meditech’s I-SugarX Glucose Monitoring System ......................................................................................................... 106 Grove Instruments’ Grove Glucometer ............................................................................................................................................ 106 Lein Applied Diagnostics .................................................................................................................................................................... 107 LighTouch Medical’s Non-Invasive Glucose Monitor ..................................................................................................................... 107 Massachusetts Institute of Technology’s Raman Spectroscopy System ................................................................................... 108 Medtronic’s PreciSense Technology ................................................................................................................................................. 108 v
Page 1 and 2: DIABETES LANDSCAPE Market, Technolo
Page 3: Diabetes Landscape: CONTENTS Table
Page 7 and 8: Diabetes Landscape: May 2012 © Esp
Page 17 and 18: Diabetes Landscape: Table of Conten

Table of Contents - Espicom

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?